"did any rprx investors here know this was on the radar??)"
yes this was mentioned by JP at some forum in the past (can't remember which)
there is also quite a bit of data on mife as pertains to breast CA, as well as loose clinical data on progestins as mitogens for breast CA (e.g. women's health initiative), so this waqs not a surprise (although i'm pleased there is actual animal data already and not just a cell culture model)
PS: there are other indications which have been bandied about for this class of drug as well which may or may not come to see the light of day
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.